Princeton, NJ · Founded 2019 · Privately Held (backing)
Developer of biopharmaceutical therapies designed to address central nervous system disorders by restoring glutamate homeostasis. iQure Pharma is based in Princeton, NJ and was founded in 2019. Its last reported valuation was $21 million in Nov 2025. It has raised $13.1 million across 4 recorded rounds; the latest was a $650,000 seed round in May 2026.
These 8 firms already write checks for companies like iQure Pharma. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.